Kevin R Sayer

Executive Chair Kevin R Sayer sold 26,759 shares (26.8K) of DXCM at $72.00 on 2026-05-21 under pre-arranged 10b5-1 plan; retains 382,482 shares.

Kevin R Sayer sold 26,759 shares of DEXCOM at $72.00 under a pre-arranged 10b5-1 trading plan, reducing his holdings by 6.5% to 382,482 shares while retaining a substantial position of 382.5K shares. The sale is scheduled per a 10b5-1 plan and therefore not discretionary. His prior trades at DXCM show mixed near-term outcomes (5 prior sales ranging from -6.0% to +20.5% in 30-day returns), and his cross-ticker track record shows an average 90-day return of -10.6% following sells, though the current price of $72.01 is -20.0% from the 52-week high and +17.0% over the past 30 days. The company posted $1,191,900,000.00 in revenue and $199,500,000.00 in net income in the latest quarter, with annual revenue growth of +15.6% and a P/E of 29.88.

DXCM CEO Sayer sells 32,498 shares at $70.38; stock down 49.7% from 52-week high, CEO retains 372,029 shares post-sale

Kevin R. Sayer, CEO and President, sold 32,498 shares of DXCOM Inc (DXCM) on 2025-03-12 at $70.38, reducing his holdings by 8.0% to 372,029 shares. The sale occurs as the stock trades 49.7% below its 52-week high of $140.45, having declined 15.7% in the prior 30 days. Sayer's prior four sales at DXCM were all well-timed at the 90-day mark, with outcomes ranging from -12.0% to -18.0%, suggesting a pattern of selling into strength relative to subsequent price weakness. However, the CEO retains substantial holdings post-transaction, and the company demonstrates solid fundamentals: $994.2M quarterly revenue, $134.6M net income, and 11.3% annual revenue growth, indicating no apparent operating distress. The sale's significance lies in whether this continues Sayer's documented pattern of well-timed exits at DXCM, or represents an exception given current valuations.

CEO Kevin Sayer sold 33,359 shares of DXCM at $86.91 on 2025-01-29 (value $2,899,367.46); retains 319,037 shares (-9.5%)

Kevin Sayer, Chairman, CEO & President, executed a substantial open-market sale of 33,359 shares for $2.9M, reducing his stake by 9.5% to 319,037 shares. His cross-ticker track record shows a 63.64% well-timed sell rate across 11 prior sales, suggesting above-average judgment on exit timing. At DXCM specifically, all 5 prior sales have been well-timed in the 90-day window—each followed by stock declines—indicating a consistent pattern of selling ahead of weakness at this ticker. DXCM is trading -37.6% from its 52-week high of $140.45 but has recovered +24.6% over 90 days and +12.7% over 30 days; the company fundamentals remain solid (24.5% annual revenue growth, $134.6M net income on $994.2M quarterly revenue), though valuation is stretched at a 50.36 P/E. The historical timing pattern at DXCM is material context for evaluating whether this sale signals confidence in near-term price strength after the recent recovery or represents a discretionary reduction ahead of potential headwinds.